Page 140 - 《中国药房》2025年14期

short-term memory algorithm for personalized tacrolimus tric population [J]. Bone Marrow Transplant，2000，26
dosing：a simple and effective time series forecasting ap‐ （6）：601-605.
proach post-lung transplantation[J]. J Heart Lung Trans‐ [25] 刘萌，张瑞麟，刘敏，等. 环孢素A 在异基因造血干细胞
plant，2025，44（3）：351-361. 移植患者体内的群体药动学研究[J]. 中国药房，2013，24
[14] SONG L，HUANG C R，PAN S Z，et al. A model based on （46）：4370-4373.
machine learning for the prediction of cyclosporin A [26] JACOBSON P A，NG J，GREEN K G，et al. Posttrans‐
trough concentration in Chinese allo-HSCT patients[J]. plant day significantly influences pharmacokinetics of cy‐
Expert Rev Clin Pharmacol，2023，16（1）：83-91. closporine after hematopoietic stem cell transplantation
[15] CHEN B，SHI H Q，LIU X X，et al. Population pharmaco‐ [J]. Biol Blood Marrow Transplant，2003，9（5）：304-311.
kinetics and Bayesian estimation of tacrolimus exposure [27] 颜辉，吴芙蓉，季鹏，等. 个体化给药辅助决策系统JPKD
in Chinese liver transplant patients[J]. J Clin Pharm Ther， 对肾移植受者他克莫司血药浓度预测能力评估[J]. 器官
2017，42（6）：679-688. 移植，2024，15（4）：630-636.
[16] 向秋林，刘玲，杨忆，等 . CYP3A5 基因多态性及五酯胶 [28] FU Q，JING Y，LIU MR G，et al. Machine learning-based
囊对肾移植术后早期他克莫司暴露及不良反应的影响 method for tacrolimus dose predictions in Chinese kidney
[J]. 中国药房，2024，35（14）：1765-1769. transplant perioperative patients[J]. J Clin Pharm Ther，
[17] TENG F，ZHANG W Y，WANG W，et al. Population phar‐ 2022，47（5）：600-608.
macokinetics of tacrolimus in Chinese adult liver trans‐ [29] PASCHIER A，DESTERE A，MONCHAUD C，et al. Ta‐
plant patients[J]. Biopharm Drug Dispos，2022，43（2）： crolimus population pharmacokinetics in adult heart trans‐
76-85. plant patients[J]. Br J Clin Pharmacol，2023，89（12）：
[18] CHEN L Z，YANG Y Y，WANG X B，et al. Wuzhi capsule 3584-3595.
dosage affects tacrolimus elimination in adult kidney [30] YANG S Y，WEI J，PAN X Q，et al. Development and
transplant recipients，as determined by a population phar‐ validation of individualized tacrolimus dosing software
macokinetics analysis[J]. Pharmgenomics Pers Med， for Chinese pediatric liver transplantation patients：a popu‐
2021，14：1093-1106. lation pharmacokinetic approach[J]. Eur J Clin Pharma‐
[19] PHARMD O C，PHD D B，et al. Tacrolimus population col，2024，80（9）：1409-1420.
pharmacokinetics and multiple CYP3A5 genotypes in [31] WOILLARD J B，LABRIFFE M，PRÉMAUD A，et al. Es‐
black and white renal transplant recipients[J]. J Clin Phar‐ timation of drug exposure by machine learning based on
macol，2018，58（9）：1184-1195. simulations from published pharmacokinetic models：the
[20] ANDREWS L M，HESSELINK D A，VAN SCHAIK R N， example of tacrolimus[J]. Pharmacol Res，2021，167：
et al. A population pharmacokinetic model to predict the 105578.
individual starting dose of tacrolimus in adult renal trans‐ [32] WANG Y P，LU X L，SHAO K，et al. Improving predic‐
plant recipients[J]. Br J Clin Pharmacol，2019，85（3）： tion of tacrolimus concentration using a combination of
601-615. population pharmacokinetic modeling and machine lear-
[21] LLOBERAS N，GRINYÓ J M，COLOM H，et al. A pro‐ ning in Chinese renal transplant recipients[J]. Front Phar‐
spective controlled，randomized clinical trial of kidney macol，2024，15：1389271.
transplant recipients developed personalized tacrolimus [33] HU K，HE S M，ZHANG C，et al. Optimizing the initial
dosing using model-based Bayesian prediction[J]. Kidney tacrolimus dosage in Chinese children with lung transplan‐
Int，2023，104（4）：840-850. tation within normal hematocrit levels[J]. Front Pediatr，
[22] CAI X J，SONG H Z，JIAO Z，et al. Population pharmaco‐ 2024，12：1090455.
kinetics and dosing regimen optimization of tacrolimus in [34] HOU J N，YANG S Y，LIU W，et al. Tacrolimus popula‐
Chinese lung transplant recipients[J]. Eur J Pharm Sci， tion pharmacokinetic model-informed precision dosing in
2020，152：105448. adult liver transplant patients[J/OL]. Naunyn Schmiede‐
[23] LIU X L，GUAN Y P，WANG Y，et al. Population pharma‐ bergs Arch Pharmacol，2025[2025-03-01]. https：//pubmed.
cokinetics and initial dosage optimization of tacrolimus in ncbi. nlm. nih. gov/40029388/. DOI：10.1007/s00210-025-
pediatric hematopoietic stem cell transplant patients[J]. 03982-7.
Front Pharmacol，2022，13：891648. （收稿日期：2025-03-03 修回日期：2025-06-25）
[24] PRZEPIORKA D，BLAMBLE D，HILSENBECK S，et al. （编辑：孙 冰）
Tacrolimus clearance is age-dependent within the pedia-

· 1818 · China Pharmacy 2025 Vol. 36 No. 14 中国药房 2025年第36卷第14期